Otitis Externa Clinical Trial
Official title:
A Prospective, Post-Market Clinical Follow-up Investigation to Verify Performance and Safety of Otinova® Ear Spray When Used in the Treatment of External Otitis Symptoms
The purpose of this study is to assess the performance and safety of Otinova® Ear Spray when used in the treatment of external otitis symptoms.
After being informed about the study and potential risks, all patients giving written informed consent will receive treatment with Otinova® Ear Spray for 7 days, twice daily. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00523120 -
Topical Voltaren in Otitis Externa
|
Phase 2 | |
| Completed |
NCT00872209 -
Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa
|
Phase 1/Phase 2 | |
| Completed |
NCT02558738 -
Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations
|
N/A | |
| Completed |
NCT02511561 -
OTO-201 for the Treatment of Otitis Externa
|
Phase 2 | |
| Terminated |
NCT01910155 -
A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa
|
Phase 3 | |
| Completed |
NCT01359098 -
Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa
|
Phase 2 | |
| Completed |
NCT01157819 -
Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis
|
Phase 2 | |
| Completed |
NCT00980876 -
A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension
|
Phase 3 |